Search results
Results from the WOW.Com Content Network
To change this template's initial visibility, the |state= parameter may be used: {{Transfusion medicine | state = collapsed}} will show the template collapsed, i.e. hidden apart from its title bar. {{Transfusion medicine | state = expanded}} will show the template expanded, i.e. fully visible. This template is part of the medical series of ...
Blood transfusion is the process of transferring blood products into a person's circulation intravenously. [1] Transfusions are used for various medical conditions to ...
The infections link is not particularly related to transfusion infections, I feel. There would be room for Blood products to feature in the template box with a heading. Snowman 14:32, 28 June 2006 (UTC) Added to template, but it's going to make some of the pages in this group quite heavy with templates. --apers0n 15:57, 28 June 2006 (UTC)
An exchange transfusion is a blood transfusion in which the patient's blood or components of it are exchanged with (replaced by) other blood or blood products. [1] The patient's blood is removed and replaced by donated blood or blood components. This exchange transfusion can be performed manually or using a machine . [2]
In the acute phase of hemolysis, blood transfusions might be necessary, or even dialysis in acute kidney failure. Blood transfusion is an important symptomatic measure, as the transfused red cells are generally not G6PD deficient and will live a normal lifespan in the recipient's circulation. Those affected should avoid drugs such as aspirin.
Cross-matching or crossmatching is a test performed before a blood transfusion as part of blood compatibility testing. Normally, this involves adding the recipient's blood plasma to a sample of the donor's red blood cells. If the blood is incompatible, the antibodies in the recipient's plasma will bind to antigens on the donor
A transfusion transmitted infection (TTI) is a virus, parasite, or other potential pathogen that can be transmitted in donated blood through a transfusion to a recipient. The term is usually limited to known pathogens, but also sometimes includes agents such as simian foamy virus which are not known to cause disease.
The incidence of TA-GvHD in immunocompromised patients receiving blood transfusions is estimated to be 0.1–1.0%, and mortality around 80–90%. Mortality is higher in TA-GvHD than in GvHD associated with bone marrow transplantation , where the engrafted lymphoid cells in the bone marrow are of donor origin (in autotransplant) and therefore ...